These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3693868)

  • 41. Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
    Bowers MB
    J Neuropsychiatry Clin Neurosci; 1996; 8(4):450-2. PubMed ID: 9116484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report.
    Ikenouchi A; Yoshimura R; Ikemura N; Utsunomiya K; Mitoma M; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1359-63. PubMed ID: 16626841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychotic patients with increased plasma HVA and MHPG or increased HVA alone.
    Bowers MB
    Biol Psychiatry; 1993 Oct; 34(8):584-6. PubMed ID: 8274591
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma level and effect of low-dose haloperidol in acute psychosis.
    Bleeker JA; Dingemans PM; Frohn-de Winter ML; van de Slooten EP
    Psychopharmacol Bull; 1984; 20(2):317-9. PubMed ID: 6728996
    [No Abstract]   [Full Text] [Related]  

  • 45. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
    Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
    Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder.
    Basterreche N; Dávila R; Zumárraga M; Arrúe A; González-Torres MA; Zamalloa MI; Anguiano JB; Guimón J
    Neuropsychobiology; 2008; 58(3-4):111-7. PubMed ID: 18997477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haloperidol blood levels in acute mania with psychosis.
    Chou JC; Czobor P; Dacpano G; Richardson N; Tuma I; Trujillo M; Cooper TB; Volavka J
    J Clin Psychopharmacol; 2001 Aug; 21(4):445-7. PubMed ID: 11476130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A biomodal distribution of plasma HVA/MHPG in the psychoses.
    Ottong SE; Garver DL
    Psychiatry Res; 1997 Mar; 69(2-3):97-103. PubMed ID: 9109177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma homovanillic acid and prolactin in Huntington's disease.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Neurochem Res; 2009 May; 34(5):917-22. PubMed ID: 18841471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychotogenic drug use and neuroleptic response.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Schizophr Bull; 1990; 16(1):81-5. PubMed ID: 1970670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
    Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
    Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of psychotic inpatients with high or low HVA levels at admission.
    Bowers MB
    Am J Psychiatry; 1991 Feb; 148(2):240-3. PubMed ID: 1670980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL
    Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP; Bowers MB; Hoffman FJ; Sackeim HA
    Biol Psychiatry; 1989 Aug; 26(4):408-12. PubMed ID: 2765601
    [No Abstract]   [Full Text] [Related]  

  • 55. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
    Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute psychosis and plasma catecholamine metabolites.
    Bowers MB; Swigar ME
    Arch Gen Psychiatry; 1987 Feb; 44(2):190. PubMed ID: 3813817
    [No Abstract]   [Full Text] [Related]  

  • 58. Haloperidol plasma concentrations in Taiwanese psychiatric patients.
    Lane HY; Lin HN; Hwu HG; Jann M; Hu WH; Chang WH
    J Formos Med Assoc; 1995 Nov; 94(11):671-8. PubMed ID: 8527974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.
    Zarifian E; Scatton B; Bianchetti G; Cuche H; Loo H; Morselli PL
    Arch Gen Psychiatry; 1982 Feb; 39(2):212-5. PubMed ID: 7065833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
    Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
    Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.